tiprankstipranks
Advertisement
Advertisement

CATX Stock Latest News

Perspective Therapeutics: EC grants OMP designation to (212Pb)VMT-alpha-NET
The FlyPerspective Therapeutics: EC grants OMP designation to (212Pb)VMT-alpha-NET
3d ago
CATX
Perspective Therapeutics management to meet virtually with BTIG
PremiumThe Fly
Perspective Therapeutics management to meet virtually with BTIG
21d ago
CATX
Perspective Therapeutics Highlights Progress in Alpha Radiopharmaceutical Pipeline
PremiumCompany Announcements
Perspective Therapeutics Highlights Progress in Alpha Radiopharmaceutical Pipeline
30d ago
8K
CATX
Perspective Therapeutics management to meet virtually with BTIG
PremiumThe Fly
Perspective Therapeutics management to meet virtually with BTIG
1M ago
CATX
3 High-Risk, High-Reward Stocks to Buy Now, According to Analysts
PremiumMarket News
3 High-Risk, High-Reward Stocks to Buy Now, According to Analysts
2M ago
CATX
GLOO
Perspective announces first patient dosed with (212Pb)VMT-alpha-NET
PremiumThe FlyPerspective announces first patient dosed with (212Pb)VMT-alpha-NET
2M ago
CATX
Perspective Therapeutics Highlights Progress in Alpha Radiopharmaceutical Pipeline
Premium
Company Announcements
Perspective Therapeutics Highlights Progress in Alpha Radiopharmaceutical Pipeline
2M ago
8K
CATX
Perspective Therapeutics shareholders approve directors and governance items
Premium
Company Announcements
Perspective Therapeutics shareholders approve directors and governance items
2M ago
8K
CATX
Perspective Therapeutics Showcases Strong Interim Radiopharma Data
PremiumCompany Announcements
Perspective Therapeutics Showcases Strong Interim Radiopharma Data
2M ago
8K
CATX
Options Volatility and Implied Earnings Moves This Week, May 18 – May 22, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves This Week, May 18 – May 22, 2026
2M ago
DE
HD
Perspective Therapeutics doses first patients in two Phase 1/2a studies
PremiumThe Fly
Perspective Therapeutics doses first patients in two Phase 1/2a studies
2M ago
CATX
CATX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CATX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
CATX
Perspective Therapeutics price target lowered to $6 from $7 at BofA
PremiumThe FlyPerspective Therapeutics price target lowered to $6 from $7 at BofA
3M ago
CATX
Perspective Therapeutics reports Q1 EPS (25c), consensus (30c)
Premium
The Fly
Perspective Therapeutics reports Q1 EPS (25c), consensus (30c)
3M ago
CATX
Perspective Therapeutics Highlights Q1 Progress and Strengthened Finances
Premium
Company Announcements
Perspective Therapeutics Highlights Q1 Progress and Strengthened Finances
3M ago
8K
CATX
Perspective Therapeutics Highlights Alpha-Targeted Oncology Strategy Update
PremiumCompany Announcements
Perspective Therapeutics Highlights Alpha-Targeted Oncology Strategy Update
3M ago
8K
CATX
Perspective Therapeutics Highlights Encouraging Interim Neuroendocrine Tumor Data
PremiumCompany Announcements
Perspective Therapeutics Highlights Encouraging Interim Neuroendocrine Tumor Data
3M ago
8K
CATX
Perspective reports results from Phase 1/2a clinical trial of (212Pb)VMT-alpha-NET
PremiumThe Fly
Perspective reports results from Phase 1/2a clinical trial of (212Pb)VMT-alpha-NET
3M ago
CATX
Perspective Therapeutics Highlights Progress in 212Pb Oncology Pipeline
PremiumCompany Announcements
Perspective Therapeutics Highlights Progress in 212Pb Oncology Pipeline
4M ago
8K
CATX
Reiterating Buy on Perspective Therapeutics: Strong Cash Runway, Improving Earnings Outlook, and Clinical Milestones Support $13 DCF Valuation
PremiumRatingsReiterating Buy on Perspective Therapeutics: Strong Cash Runway, Improving Earnings Outlook, and Clinical Milestones Support $13 DCF Valuation
4M ago
CATX
Perspective Therapeutics price target raised to $13 from $12 at H.C. Wainwright
Premium
The Fly
Perspective Therapeutics price target raised to $13 from $12 at H.C. Wainwright
4M ago
CATX
Perspective Therapeutics price target raised to $8 from $7 at UBS
Premium
The Fly
Perspective Therapeutics price target raised to $8 from $7 at UBS
4M ago
CATX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >